Related references
Note: Only part of the references are listed.Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D. Banister et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids
Ritva Karinen et al.
FORENSIC SCIENCE INTERNATIONAL (2015)
Structure-activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
Samuel D. Banister et al.
FORENSIC TOXICOLOGY (2015)
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
M. E. Lynch et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors
Tomohiko Irie et al.
NEUROPHARMACOLOGY (2015)
Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues
L. J. Schep et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
N. A. Balenga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The cannabinoid receptor 1 and its role in influencing peripheral metabolism
L. O'Keefe et al.
DIABETES OBESITY & METABOLISM (2014)
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
E. Martinez-Pinilla et al.
EXPERIMENTAL NEUROLOGY (2014)
Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22
George Behonick et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2014)
XLR-11 and UR-144 in Washington State and State of Alaska Driving Cases
Asa Louis et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2014)
Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55
V. Rempel et al.
MEDCHEMCOMM (2014)
The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse
Samuel D. Banister et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products
Nahoko Uchiyama et al.
FORENSIC TOXICOLOGY (2013)
Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold
Viktor Rempel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
Alexander Fuchs et al.
PLOS ONE (2013)
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55
Viktor Rempel et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
GPR18 in microglia: implications for the CNS and endocannabinoid system signalling
D. McHugh
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice
Jenny L. Wiley et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists
Viktor Rempel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure-activity relationships, physicochemical properties and biological activity
Antoni R. Blaazer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Identification of a Potent and Selective Cannabinoid CB, Receptor Antagonist from Auxarthron reticulatum
Mahmoud Fahmi Elsebai et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity
Jennifer M. Frost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists
Andrea Behrenswerth et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Spice: A never ending story?
Rainer Lindigkeit et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2009)
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Ankur Kapur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Indol-3-yl-tetramethylcyclopropyl ketones:: Effects of indole ring substitution on CB2 cannabinoid receptor activity
Jennifer M. Frost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Structure-activity relationships for 1-alkyl-3-(l-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors:: steric and electronic effects of naphthoyl substituents.: New highly selective CB2 receptor agonists
JW Huffman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties
ST Wrobleski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
3-indolyl-1-naphthylmethanes:: New cannabimimetic Indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor
JW Huffman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Pharmacology and effects of cannabis: a brief review
CH Ashton
BRITISH JOURNAL OF PSYCHIATRY (2001)
Share Paper
